SEC Form D · Amendment · filed November 24, 2020
ANSUN BIOPHARMA, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Donald Payne · SAN DIEGO, CADirectorDave Chenn · SAN DIEGO, CADirectorKaren Liu · Rockville, MDDirectorAimin Wu · SAN DIEGO, CADirectorYi Shi · Grand Cayman, Cayman IslandsDirectorMichael Chao · Las Vegas, NVDirectorMichael Chang · Santa Clara, CADirectorAllen Chao · SAN DIEGO, CADirectorNancy Chang · Houston, TXExec · DirectorNina Barton · New York, NYDirectorLarry E. Chachkes · MIAMI BEACH, FLExec · DirectorDon A. Mccarthy · New York, NYDirectorVadim Khramov · Boca Raton, FLDirectorKaren J. Jakobi · Irvine, CADirectorBrian A. Meyer · New York, NYDirectorPhilip M. Bilden · Palm Beach, FLDirectorCP Collective Depositor, LLC · Newport Beach, CADirectorCP Collective Apartments Manager, LLC · Newport Beach, CADirectorYining Zhao · SAN DIEGO, CAExecAdam I. Gunasekara · New York, NYDirectorSaurabh K. Srivastava · New York, NYDirectorSachin K. Srivastava · New York, NYDirectorThomas Casten · Hinsdale, ILDirectorBill Hermann · Port Angeles, WADirectorBenjamin Maritz · SEATTLE, WADirectorLisa Martensson · Dublin 1, IrelandDirectorJohn Hamrock · Dublin 1, IrelandDirectorKarl Mceneff · Dublin 1, IrelandExec · DirectorYining Zhao · SAN DIEGO, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗